Cargando…

Therapeutics to harness the immune microenvironment in multiple myeloma

Multiple myeloma (MM) remains an incurable, genetically heterogeneous disease characterized by the uncontrolled proliferation of transformed plasma cells nurtured within a permissive bone marrow (BM) microenvironment. Current therapies leverage the unique biology of MM cells and target the immune mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ignatz-Hoover, James J., Driscoll, James J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511806/ https://www.ncbi.nlm.nih.gov/pubmed/36176763 http://dx.doi.org/10.20517/cdr.2022.23

Ejemplares similares

Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma
por: Swamydas, Muthulekha, et al.
Publicado: (2022)

Harnessing the Immune System to Fight Multiple Myeloma
por: Krejcik, Jakub, et al.
Publicado: (2021)

Current and Emerging Strategies to Treat Urothelial Carcinoma
por: Rani, Berkha, et al.
Publicado: (2023)

Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes
por: Ignatz-Hoover, James J., et al.
Publicado: (2022)

The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021)

Novel therapies emerging in oncology to target the TGF-β pathway
por: Kim, Byung-Gyu, et al.
Publicado: (2021)

Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment
por: Elion, David L., et al.
Publicado: (2018)

Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
por: Andorko, James I., et al.
Publicado: (2014)

Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma
por: Malek, Ehsan, et al.
Publicado: (2023)

Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
por: Yamamoto, Leona, et al.
Publicado: (2021)

Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction
por: Rana, Priyanka S., et al.
Publicado: (2022)

Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm
por: Keller, Alana L., et al.
Publicado: (2022)

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
por: Reina-Ortiz, Chantal, et al.
Publicado: (2022)

Targeting the Microenvironment for Treating Multiple Myeloma
por: Neumeister, Peter, et al.
Publicado: (2022)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)

Immunological Dysregulation in Multiple Myeloma Microenvironment
por: Romano, Alessandra, et al.
Publicado: (2014)

Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance
por: Holthof, Lisa C., et al.
Publicado: (2020)

Bone Marrow Microenvironment in Multiple Myeloma Progression
por: Manier, S., et al.
Publicado: (2012)

Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer
por: Kather, Jakob Nikolas, et al.
Publicado: (2019)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Ho, Matthew, et al.
Publicado: (2022)

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
por: García-Ortiz, Almudena, et al.
Publicado: (2021)

Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
por: Alipoor, Shamila D., et al.
Publicado: (2023)

Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020)

Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics
por: Le, Ilene, et al.
Publicado: (2022)

Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
por: Sulsenti, Roberta, et al.
Publicado: (2023)

Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
por: Berardi, Simona, et al.
Publicado: (2013)

Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
por: Choi, Yechan, et al.
Publicado: (2023)

Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities
por: Botta, Cirino, et al.
Publicado: (2021)

Microenvironment drug resistance in multiple myeloma: emerging new players
por: Di Marzo, Lucia, et al.
Publicado: (2016)

DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment
por: Saitoh, Takayuki, et al.
Publicado: (2021)

Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling
por: Wang, Jin, et al.
Publicado: (2022)

The Immune Microenvironment in Multiple Myeloma Progression at a Single-cell Level
por: Schinke, Carolina, et al.
Publicado: (2023)

Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2023)

Harnessing the immune system in glioblastoma
por: Brown, Nicholas F., et al.
Publicado: (2018)

The Emerging Role of Extracellular Vesicle-Associated RNAs in the Multiple Myeloma Microenvironment
por: Khalife, Jihane, et al.
Publicado: (2021)

Molecular Crosstalk between Chromatin Remodeling and Tumor Microenvironment in Multiple Myeloma
por: Chakraborty, Chandraditya, et al.
Publicado: (2022)

Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
por: Abdi, Jahangir, et al.
Publicado: (2014)

Road testing new CAR design strategies in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2022)

Potential Therapeutic Roles of Exosomes in Multiple Myeloma: A Systematic Review
por: Li, Mengzhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bl7lbopjt5rp8avij61i23s50f